Event agenda

Welcome by Fran Van Heuverswyn, Flanders Vaccine

Next-Generation Biomanufacturing: One Health Approaches for Vaccines and Therapeutics,

This session, hosted by Swiftpharma, explores innovative plant-based technologies and their applications, ranging from novel therapeutic solutions for cancer to the development of cancer vaccines in both humans and animals.

Coffe Break

Next-Generation Biomanufacturing: One Health Approaches for Vaccines and Therapeutics

Martin Friede, Senior Advisor Medicines Patent Pool, will share his insights and thoughts on unmet needs for Biomanufacturing processes in LMIC. The session will conclude with an interactive panel discussion with the speakers and the audience.

Q&A panel discussion with the speakers and the audience

Welcome by Flanders Vaccine

Welcome by Julie Bynens, secretary-general Flanders Chancellery and Foreign Office

Keynote: Combatting emerging viruses in a changing world - Prof. Dr. Ab Osterhaus, University of Veterinary Medicine Hannover

An overview will be given of emerging virus infections that have had a major impact on human and animal populations in the past decades: from predisposing factors and virus discovery to intervention strategies.

Archetypes of pathogens with pandemic potential - Prof. Dr. Niel Hens, University of Hasselt & Antwerp

In this work, Prof. Dr. Niel Hens will review key epidemiological parameters of 19 pathogens with pandemic potential and use an unsupervised clustering approach to group them into six distinct epidemiological archetypes.

Climate Change and Mosquito-Borne Diseases: A Call for Integrated Action - Prof. Ruth Müller, Institute of Tropical Medicine

Climate change is shifting mosquito-borne diseases like malaria, dengue, and West Nile virus. Tackling this requires surveillance, vector management, vaccine innovation, and cross-disciplinary collaboration to safeguard public health.

Coffee Break

History of the Belgian vaccine ecosystem – Prof. em. Pierre Van Damme, University of Antwerp

Pitch Session: Innovation pitches

Pitching cutting-edge One Health innovations, from digital twin modeling and vaccination recording to new animal models for influenza research and intradermal dose-sparing techniques for pandemic preparedness. Join us to discover the latest innovations!

Lunch & Networking

Lunch & 1-1 Meetings via the B2Match networking app

Licensure of Chikungunya Vaccines Without Formal Efficacy Data: A Case Study in Regulatory Strategy and Real-World Evidence.

This presentation reviews regulatory pathways for vaccine licensure without phase 3 efficacy trials, using the case of Chikungunya Vaccines to illustrate the role of surrogate endpoints and accelerated approvals.

Closing the Evidence Gap: Advancing Infant and Maternal Mpox Vaccination in the DRC: A Phase 3 Trial on MVA-BN - Ynke Larivière, University of Antwerp

This presentation will provide an overview of the PregInPoxVac project, a Phase 3 vaccine trial taking place in Boende, DRC.

Vaccine innovation against old and new threats: insights from the Vaccines Europe 2024 pipeline review - Charlotte Vernhes, Director Scientific and Medical Affairs, Vaccines Europe

Key insights from the Vaccines Europe 2024 Pipeline Review, incl. AMR & climate impact

Coffee Break

Strengthening Regional Health Security in Africa through Flemish Partnerships - Sander Spanoghe, Chancellery and Foreign Office

Licensing for Public Health: The MPP model - Johnny Vlaminck , Medicines Patent Pool

Insights from the Flanders Vaccine Strategic Network

This session explores how Flanders Vaccine is perceived by its strategic partners and what they envision for the network’s future.

Pitch Award & Closing Word

Reception & Networking

Enjoy a drink and a bite & 1-1 Meetings via the B2Match networking app